We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


  Silver Agilent provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
20 Oct 2021 - 22 Oct 2021
21 Oct 2021 - 24 Oct 2021
Virtual Venue

ALPK3 Truncating Variants Cause Autosomal Dominant Hypertrophic Cardiomyopathy

By LabMedica International staff writers
Posted on 07 Oct 2021
Print article
Image: The SureSelect Target Enrichment System is a highly efficient hybrid selection technique for optimizing next-generation sequencing (Photo courtesy of Agilent Technologies)
Image: The SureSelect Target Enrichment System is a highly efficient hybrid selection technique for optimizing next-generation sequencing (Photo courtesy of Agilent Technologies)
In hypertrophic cardiomyopathy, heart muscles are thicker, which can make it harder for the heart to receive and pump blood. While in most cases the condition will not affect daily life, it can cause heart failure and is frequently cited as the most common cause of sudden unexpected death in young people.

Hypertrophic cardiomyopathy (HCM) is a genetic condition caused by a change or mutation in one or more genes and is passed on through families. A child of someone with HCM has a 50% chance of inheriting the condition. Most people with HCM have no symptoms or feel stable throughout their life. However, others do have symptoms. Some people find that their symptoms worsen in later life. This may be because their heart muscle has slowly become stiffer, making it harder for the heart to pump.

A large team of international scientists led by those at the University College London (London, UK) analyzed the genomes of 2,817 people with hypertrophic cardiomyopathy referred from centers in Spain, the UK, Denmark, Russia, Latvia, Brazil, and Argentina. The discovery cohort comprised 770 consecutively evaluated unrelated patients with HCM. The aim of their study was to determine the frequency of heterozygous truncating alpha-protein kinase (ALPK3) variants (ALPK3tv) in patients with HCM and confirm their pathogenicity using burden testing in independent cohorts and family co-segregation studies.

From 2018 to 2020, ALPK3 was sequenced using next-generation sequencing in 4,904 consecutive unrelated probands with inherited cardiac conditions referred for molecular genetic diagnosis. Coding exons and intronic boundaries of 261 genes related to inherited cardiovascular diseases and sudden cardiac death (SCD) were captured using a custom probe library using the SureSelect Target Enrichment Kit for Illumina paired-end multiplexed sequencing method, (Agilent Technologies, Santa Clara, CA, USA), and sequenced using the HiSeq 1500 platform (Illumina, San Diego, CA, USA).

The investigators reported that in a discovery cohort of 770 index patients with HCM, 12 (1.56%) were heterozygous for ALPK3tv [odds ratio (OR) 16.11) compared to the Genome Aggregation Database (gnomAD) population. In a validation cohort of 2,047 HCM probands, 32 (1.56%) carried heterozygous ALPK3tv (OR 16.17). In comparison with a cohort of 1,679 genotyped patients with HCM with and without pathogenic sarcomere gene variants (SP+ and SP−), ALPK3tv carriers had a higher prevalence of apical/concentric patterns of hypertrophy (60%) and of a short PR interval (10%).

Luis R. Lopes, MD, PhD, a Consultant Cardiologist and the lead author of the study, said, “Hypertrophic cardiomyopathy is an extremely common genetic condition. Earlier, small-scale studies suggested that variants in the ALPK3 gene could be a cause of a rare pediatric form of cardiomyopathy, but only when two abnormal copies were inherited. We have now proved that just one abnormal copy is enough to cause hypertrophic cardiomyopathy in adults, looking at a large number of patients and families. This form of inheritance (autosomal dominant) is much more prevalent, as inheriting just one abnormal copy of a gene is more likely than inheriting two. Identifying a new genetic cause is important as it opens up new possibilities for potential treatment. It also helps families who have been affected by the condition, but who did not know why, to know that a cause has been found for their specific case.” The study was published on August 21 2021 in the European Heart Journal.

Related Links:
University College London
Agilent Technologies

Gold Supplier
Molecular Diagnostic System
Singuway 9600 Pro
Silver Supplier
Quality Control Material
Multichem U
COVID-19 Severity Algorithm
Atellica COVID-19 Severity Algorithm
Cardiovascular Disease POC Analyzer
cobas h 232 POC System

Print article


Clinical Chem.

view channel
Image: Simoa is an ultra-sensitive immunoassay technology that allow detection of proteins and nucleic acids at lowest possible levels (Photo courtesy of Quanterix)

Plasma Amyloid-β 42/40 Assays Compared in Alzheimer Disease

Blood-based tests for brain amyloid-β (Aβ) pathology are needed for widespread implementation of Alzheimer disease (AD) biomarkers in clinical care and to facilitate patient screening and monitoring of... Read more


view channel
Image: Bone marrow aspirate from a patient with peripheral T-cell lymphoma (Photo courtesy of Peter Maslak, MD)

Mutation Analysis Links Angioimmunoblastic T-Cell Lymphoma to Clonal Hematopoiesis

Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of lymphoid tumors and encompass peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), angioimmunoblastic T-cell lymphoma (AITL), and... Read more


view channel
Image: The BD LSRFortessa X-20 Cell Analyzer can be configured with up to five lasers to detect up to 20 parameters simultaneously to support ever increasing demands in multicolor flow cytometry (Photo courtesy of BD Biosciences)

Highly Multiplexed Cell Surface Protein Analyzed Via Flow Cytometry

Modern immunologic studies increasingly requires high-dimensional analyses to understand the complex milieu of cell types that comprise the tissue microenvironments of disease. One of the cornerstones... Read more


view channel
Image: Characteristic bronchoalveolar lavage findings of diffuse alveolar hemorrhage (Photo courtesy of Peter C. Bauer, MD)

Bronchoalveolar Lavage Cell Pattern Determined for Diffuse Alveolar Hemorrhage

Diffuse alveolar hemorrhage (DAH) is a clinicopathological syndrome that describes the accumulation of intra-alveolar red blood cells originating from the alveolar capillaries. DAH can induce severe respiratory... Read more


view channel
Image: GastroPanel Quick Test (Photo courtesy of Biohit Healthcare)

Biohit’s Innovative GastroPanel Quick Test Receives CE Mark

Biohit Healthcare’s (Helsinki, Finland) GastroPanel Quick Test, the latest innovation in its unique GastroPanel product family, is now CE marked. The GastroPanel Quick Test is intended for diagnosing... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.